Search Within

Helena Alexandra Yu

Formats
  1. Meeting Abstract (162)
  2. Journal Article (109)
  3. Editorial (9)
  4. Review (7)
  5. Book Section (2)
  6. Correspondence (2)
  7. Conference Paper (1)
Groups
  1. Department of Medicine (292)
  2. Solid Tumor Oncology Division (292)
  3. Thoracic Oncology (292)
  4. GSK Faculty (121)
  5. Department of Pathology and Laboratory Medicine (105)
  6. Human Oncology and Pathogenesis Program (102)

More Groups

People
  1. Gregory Riely (108)
  2. Mark Kris (95)
  3. Marc Ladanyi (71)
  4. Charles Rudin (58)
  5. Maria Arcila (56)
  6. Alexander Drilon (36)

More People

Years
  1. 2025 (21)
  2. 2024 (28)
  3. 2023 (30)
  4. 2022 (33)
  5. 2021 (30)
  6. 2020 (15)

More Years

Publications
  1. Journal of Clinical Oncology (75)
  2. Journal of Thoracic Oncology (63)
  3. Annals of Oncology (27)
  4. Clinical Cancer Research (18)
  5. International Journal of Radiation Oncology, Biology, Physics (14)
  6. Cancer Discovery (9)

More Publications

Publishers
  1. Elsevier Inc. (86)
  2. American Society of Clinical Oncology (85)
  3. American Association for Cancer Research (31)
  4. Oxford University Press (31)
  5. Nature Publishing Group (12)
  6. Elsevier Science, Inc. (7)

More Publishers

Results (292)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Acquired resistance of EGFR-mutant lung cancer to AT790M-specificEGFR inhibitor: Emergence of a third mutation (C797S) in the EGFR tyrosine kinase domain
    Journal Article

    Yu, H. A.; Tian, S. K.; Drilon, A. E.; Borsu, L.; Riely, G. J.; Arcila, M. E.; Ladanyi, M.
    JAMA Oncology (2015)

    Fulltext@MSK | Save
  • Activity of rociletinib in EGFR mutant NSCLC patients with a history of CNS involvement
    Meeting Abstract

    Camidge, D. R.; Sequist, L. V.; Soria, J. C.; Wakelee, H. A.; Ou, S. H.; Goldman, J. W.; Papadimitrakopoulou, V.; Gadgeel, S.; Mekhail, T.; Oxnard, G. R.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • A phase 1 study of erlotinib and ruxolitinib in patients with EGFR-mutant lung cancers and acquired resistance to erlotinib therapy
    Meeting Abstract

    Yu, H.; Perez, L. A.; Sima, C. S.; Li, B. T.; Smith-Marrone, S.; Iqbal, A.; Paik, P.; Drilon, A.; Kris, M. G.; Bromberg, J.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Clinically adoption of MSK-IMPACT, a hybridization capture-based next generation sequencing assay, for the assessment of lung adenocarcinomas
    Meeting Abstract

    Arcila, M. E.; Zehir, A.; Yu, H.; Drilon, A.; Li, B. T.; Riely, G. J.; Rekhtman, N.; Lin, O.; Hyman, D.; Berger, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Rociletinib in NSCLC patients with negative central testing for T790M in TIGER-X
    Meeting Abstract

    Wakelee, H. A.; Sequist, L. V.; Gadgeel, S.; Soria, J. C.; Goldman, J. W.; Yu, H.; Camidge, D. R.; Solomon, B. J.; Matheny, S.; Despain, D.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Dose optimization of rociletinib for EGFR mutated NSCLC
    Meeting Abstract

    Goldman, J. W.; Wakelee, H. A.; Gadgeel, S.; Camidge, D. R.; Solomon, B. J.; Yu, H.; Oxnard, G. R.; Ou, S. H.; Papadimitrakopoulou, V.; Perol, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Response to MET inhibitors in stage IV lung adenocarcinoma patients with mutations that cause MET exon 14 skipping
    Meeting Abstract

    Paik, P.; Drilon, A.; Yu, H.; Rekhtman, N.; Borsu, L.; Ginsberg, M.; Berger, M.; Ladanyi, M.; Rudin, C. M.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Rapid, highly sensitive assay for EGFR T790M mutation detection using droplet digital PCR technology on NGS libraries
    Meeting Abstract

    Borsu, L.; Intrieri, J.; Momin, Z.; Yu, H.; Riely, G.; Ladanyi, M.; Arcila, M.
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • Dose optimization of rociletinib for EGFR mutated NSCLC: Benefit/risk analysis from the TIGER-X trial
    Meeting Abstract

    Soria, J. C.; Goldman, J. W.; Wakelee, H.; Gadgeel, S.; Camidge, D. R.; Solomon, B.; Yu, H.; Oxnard, G. R.; Ou, S. H.; Papadimitrakopoulou, V.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Rociletinib treatment and outcomes in non-small cell lung cancer (NSCLC) patients with negative central testing for T790M
    Meeting Abstract

    Solomon, B.; Wakelee, H.; Sequist, L. V.; Gadgeel, S.; Soria, J. C.; Goldman, J. W.; Yu, H.; Camidge, D. R.; Papadimitrakopoulou, V.; Matheny, S.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save